Arrowhead Pharmaceuticals (ARWR) Return on Equity [ROE] (2011 - 2026)
Arrowhead Pharmaceuticals (ARWR) posted Return on Equity [ROE] of -51.11% for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 24.64 percentage points from -26.47% a year earlier and down 4.30 percentage points from the prior quarter.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Arrowhead Pharmaceuticals' Return on Equity [ROE] came in at 8.67%, up 263.65 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a five-year change of +32.63 percentage points (FY2020 to FY2025).
- In prior fiscal years, Arrowhead Pharmaceuticals' Return on Equity [ROE] was -254.98% in FY2024 (-195.66 pp), -59.33% in FY2023 (-16.65 pp), -42.67% in FY2022 (-10.32 pp) and -32.36% in FY2021 (-8.40 pp).
- The fiscal Q3 2026 figure stands as the lowest quarterly Return on Equity [ROE] since fiscal Q1 2025.
- On a year-over-year basis, Return on Equity [ROE] increased in four of the last eight quarters, with an average year-over-year change of +52.46 percentage points.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was fiscal Q1 2026, with a gain of 569.46 percentage points; the weakest was fiscal Q1 2025, with a drop of 394.23 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior fiscal quarters was -46.81% (Q2 2026), 43.82% (Q1 2026) and 5.89% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Arrowhead Pharmaceuticals | 9.06 Bn | 3.84 Bn | - | -51.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -51.11% |
| Mar 31, 2026 | -46.81% |
| Dec 31, 2025 | 43.82% |
| Sep 30, 2025 | 5.89% |
| Jun 30, 2025 | -26.47% |
| Mar 31, 2025 | -41.79% |
| Dec 31, 2024 | -525.65% |
| Sep 30, 2024 | -230.06% |
| Jun 30, 2024 | -131.20% |
| Mar 31, 2024 | -142.73% |
| Dec 31, 2023 | -131.42% |
| Sep 30, 2023 | -62.55% |
| Jun 30, 2023 | -43.49% |
| Mar 31, 2023 | -35.32% |
| Dec 31, 2022 | -38.16% |
| Sep 30, 2022 | -39.55% |
| Jun 30, 2022 | -33.23% |
| Mar 31, 2022 | -27.11% |
| Dec 31, 2021 | -46.84% |
| Sep 30, 2021 | -33.31% |
API Access
Arrowhead Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();